Dr. Glen T. Porter, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 872 N 2000 W, Suite A, Pleasant Grove, UT 84062 Phone: 801-492-8900 |
News Archive
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company's new drug application, the Zushima Analgesic Aerosol Spray.
Inhibitex, Inc., today announced its financial results for the third quarter ended September 30, 2009. The Company held cash, cash equivalents and short-term investments of $21.1 million at September 30, 2009, as compared to $33.1 million at December 31, 2008.
Among tuberculosis (TB) patients who were underweight when diagnosed, those who subsequently regained less than five percent of their weight during the first two months of treatment had a significantly increased risk of disease relapse.
A new company, DNAcare Systems, is to be formed at the University of Newcastle upon Tyne, based on research by skin cancer expert Dr Mark Birch-Machin and colleagues.
› Verified 2 days ago